Subscribe
shutterstock_284823155_constantin_stanciu
Constantin Stanciu / Shutterstock.com
11 June 2020AmericasSarah Morgan

US states sue 26 drugmakers over alleged price fixing

A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
Glenmark becomes fifth generic to be charged with US antitrust violations
2 July 2020   Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.
Americas
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
2 July 2020   Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Americas
Sun Pharma to pay $205m over generics price-fixing
24 July 2020   A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Generics
Glenmark becomes fifth generic to be charged with US antitrust violations
2 July 2020   Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.
Americas
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
2 July 2020   Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Americas
Sun Pharma to pay $205m over generics price-fixing
24 July 2020   A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.

More on this story

Generics
Glenmark becomes fifth generic to be charged with US antitrust violations
2 July 2020   Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.
Americas
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
2 July 2020   Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Americas
Sun Pharma to pay $205m over generics price-fixing
24 July 2020   A subsidiary of India’s Sun Pharma has agreed to pay more than $200 million to settle charges related to a generics price-fixing investigation.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility